Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Publication year range
1.
Actas Dermosifiliogr ; 113(2): 187-188, 2022 Feb.
Article in English, Spanish | MEDLINE | ID: mdl-35244563
4.
Clin Exp Dermatol ; 45(6): 727-731, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32311113

ABSTRACT

Lichen planus pemphigoides (LPP) is a rare autoimmune subepidermal blistering disease characterized by the coexistence of both lichen planus and either bullous pemphigoid or mucous membrane pemphigoid (MMP) features. Frontal fibrosing alopecia (FFA) is a scarring alopecia, generally considered a form of lichen planopilaris. We report two patients with concomitant FFA and MPP. Patient 1 was a 73-year-old woman with the clinical and histological diagnosis of oral lichen planus. In addition, she presented alopecic plaques in the parietal area with blisters, immunohistologically compatible with Brunsting-Perry pemphigoid, a variant of MMP. During follow-up, the patient also developed FFA. Patient 2 was a 70-year-old woman with a history of ocular inflammation and desquamative gingivitis, who was diagnosed with MMP based on a conjunctival biopsy. She also had clinical features of FFA. ELISA and frontal biopsy confirmed the diagnoses of MMP and FFA. In conclusion, we report two patients with MMP associated with FFA, and discuss whether this association is a new variant of LPP or an incidental finding.


Subject(s)
Alopecia/complications , Lichen Planus/complications , Mouth Diseases/pathology , Mouth Mucosa/pathology , Pemphigoid, Benign Mucous Membrane/complications , Aged , Alopecia/pathology , Female , Gingivitis/complications , Humans , Lichen Planus/pathology , Pemphigoid, Benign Mucous Membrane/pathology , Scalp/pathology
5.
Actas Dermosifiliogr ; 105(4): 328-46, 2014 May.
Article in English, Spanish | MEDLINE | ID: mdl-23540594

ABSTRACT

Bullous pemphigoid (BP) is an autoimmune subepidermal bullous disease in which autoantibodies are directed against components of the basement membrane. Most of these antibodies belong to the immunoglobulin G class and bind principally to 2 hemidesmosomal proteins: the 180-kD antigen (BP180) and the 230-kD antigen (BP230). It is the most common blistering disease in the adult population in developed countries, with an estimated incidence in Spain of 0.2 to 3 cases per 100,000 inhabitants per year. The disease primarily affects older people, although it can also occur in young people and even in children. In recent years, advances in clinical practice have led to a better understanding and improved management of this disorder. These advances include new diagnostic techniques, such as enzyme-linked immunosorbent assay for BP180 and new drugs for the treatment of BP, with diverse therapeutic targets. There is, however, still no international consensus on guidelines for the management of BP. This article is an updated review of the scientific literature on the treatment of BP. It focuses primarily on evidence-based recommendations and is written from a practical standpoint based on experience in the routine management of this disease.


Subject(s)
Pemphigoid, Bullous/diagnosis , Pemphigoid, Bullous/therapy , Algorithms , Humans , Practice Guidelines as Topic
SELECTION OF CITATIONS
SEARCH DETAIL
...